⌘K

Home/Filings/4/0001078782-15-001351

4//SEC Filing

VOLITIONRX LTD 4

Accession 0001078782-15-001351

$VNRXCIK 0000093314operating

View on SEC.gov Company Profile

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:28 PM ET

Size

5.4 KB

Accession

0001078782-15-001351

Insider Transaction Report

Form 4

Period: 2015-08-17

VOLITIONRX LTDVNRX

KRATOCHVIL DAVID MATTHEW

Chief Financial Officer

Transactions

Award
Stock Option
2015-08-17+75,000→ 75,000 total
Exercise: $3.75From: 2015-08-17Exp: 2020-08-17→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]A total of 75,000 Options were granted on August 17, 2015 under the Company's 2011 Equity Incentive Plan. The Options vest in full on the date of grant.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000093314

Filing Metadata

Form type: 4
Filed: Aug 16, 8:00 PM ET
Accepted: Aug 17, 5:28 PM ET
Size: 5.4 KB

View on SEC.gov